DATATRAK Signs Contract for Eight-Year, Phase IV Study

CLEVELAND, Feb. 1 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the contract signing for a Phase IV, eight-year, 500-site, 5,000-patient study worth appro

Advertisement:

read more

http://digg.com/u1M2nR